These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2412983)

  • 1. Drug-induced alterations in muscle tissue oxygen pressure in patients with arterial occlusive disease.
    Creutzig A; Alexander K
    Int J Microcirc Clin Exp; 1985; 4(2):173-81. PubMed ID: 2412983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Creutzig A; Creutzig H; Alexander K
    Eur J Clin Invest; 1986 Dec; 16(6):480-5. PubMed ID: 3104047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle tissue oxygen pressure in patients with arterial occlusive disease.
    Creutzig A; Wrabetz W; Lux M; Alexander K
    Microvasc Res; 1985 May; 29(3):350-9. PubMed ID: 3158800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease.
    Creutzig A; Caspary L; Alexander K
    Klin Wochenschr; 1990 Feb; 68(4):207-12. PubMed ID: 2314008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MR-Imaging of lower leg muscle perfusion].
    Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
    Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vascular reconstructions on tissue gas tensions in calf muscles of patients with occlusive arterial disease.
    Jussila EJ; Niinikoski J
    Ann Chir Gynaecol; 1981; 70(2):56-60. PubMed ID: 6797342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intra-arterial administration of prostaglandin E1 on rat cremaster muscle microcirculation.
    Natsui H; Yanagi K; Nakayama Y; Ohshima N
    In Vivo; 2001; 15(2):133-8. PubMed ID: 11317517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen pressure in ischemic muscle tissue of patients with chronic occlusive arterial diseases.
    Ehrly AM; Schroeder W
    Angiology; 1977 Feb; 28(2):101-8. PubMed ID: 869271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous and intra-arterial infusions of prostaglandin E1 on canine hindlimb blood flow distribution.
    Lynch TG; Hobson RW; Barbalinardo JP; Kerr JC
    Surgery; 1984 Jul; 96(1):35-41. PubMed ID: 6539953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effect of xanthinol nicotinate on the muscle clearance of 133Xenon.
    Szilvási I; Molnár G
    Ther Hung; 1973; 21(3-4):114-6. PubMed ID: 4806418
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a 3-month-interval running exercise in combination with vasodilative therapy on microcirculation of the lower leg in peripheral arterial circulation disorders (stage I and II)].
    Siewert H; Winterfeld HJ; Strangfeld D; Schmidt HH; Correns HJ
    Z Alternsforsch; 1983; 38(5):377-81. PubMed ID: 6659566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Oxygen pressure values in the ischemic muscle tissue of patients with chronic occlusive arterial diseases.
    Ehrly AM; Schroeder W
    Arzneimittelforschung; 1976; 26(6):1238. PubMed ID: 989434
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin surface oxygen pressure in healthy volunteers and patients with arterial occlusive disease.
    Creutzig A; Caspary L; Alexander K
    Int J Microcirc Clin Exp; 1991 Aug; 10(3):231-40. PubMed ID: 1955281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of prostaglandin E1 on muscular tissue-PO2 in patients with diabetic gangrene.
    Heinrich R; Krawzak HW; Strosche H
    Adv Exp Med Biol; 1989; 248():699-704. PubMed ID: 2506745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double-blind study of the effect of various intra-arterial/intravenous prostaglandin E1 doses on hemodynamics and prostaglandin E1 metabolites].
    Rudofsky G; Peskar BA
    Vasa Suppl; 1991; 33():345. PubMed ID: 1788751
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transcutaneous oxygen pressure during intra-arterial infusions].
    Creutzig A; Dau D; Alexander K
    Vasa; 1984; 13(3):207-12. PubMed ID: 6485524
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the muscle flow (determinated with 133 xenon) in the lower limbs after intra-arterial injection of acetylcholine in normal subjects and in patients with arterial diseases].
    Nuzzaci G; Fantini F; Viola S; Pesciullesi E; Boccuni M
    Minerva Cardioangiol; 1973; 21(7):503-12. PubMed ID: 4756345
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanisms of action of prostaglandin E1 in therapy of peripheral arterial occlusive diseases].
    Weiss T
    Vasa; 2003 Nov; 32(4):187-92. PubMed ID: 14694766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.